» Articles » PMID: 38615232

On the Role of Dysferlin in Striated Muscle: Membrane Repair, T-tubules and Ca Handling

Overview
Journal J Physiol
Specialty Physiology
Date 2024 Apr 14
PMID 38615232
Authors
Affiliations
Soon will be listed here.
Abstract

Dysferlin is a 237 kDa membrane-associated protein characterised by multiple C2 domains with a diverse role in skeletal and cardiac muscle physiology. Mutations in DYSF are known to cause various types of human muscular dystrophies, known collectively as dysferlinopathies, with some patients developing cardiomyopathy. A myriad of in vitro membrane repair studies suggest that dysferlin plays an integral role in the membrane repair complex in skeletal muscle. In comparison, less is known about dysferlin in the heart, but mounting evidence suggests that dysferlin's role is similar in both muscle types. Recent findings have shown that dysferlin regulates Ca handling in striated muscle via multiple mechanisms and that this becomes more important in conditions of stress. Maintenance of the transverse (t)-tubule network and the tight coordination of excitation-contraction coupling are essential for muscle contractility. Dysferlin regulates the maintenance and repair of t-tubules, and it is suspected that dysferlin regulates t-tubules and sarcolemmal repair through a similar mechanism. This review focuses on the emerging complexity of dysferlin's activity in striated muscle. Such insights will progress our understanding of the proteins and pathways that regulate basic heart and skeletal muscle function and help guide research into striated muscle pathology, especially that which arises due to dysferlin dysfunction.

Citing Articles

Metabolic dysregulation contributes to the development of dysferlinopathy.

Furrer R, Dilbaz S, Steurer S, Santos G, Karrer-Cardel B, Ritz D Life Sci Alliance. 2025; 8(5).

PMID: 40021220 PMC: 11871293. DOI: 10.26508/lsa.202402991.


Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells.

Anwar S, Roshmi R, Woo S, Haque U, Arthur Lee J, Duddy W Mol Ther Nucleic Acids. 2025; 36(1):102443.

PMID: 39967852 PMC: 11834094. DOI: 10.1016/j.omtn.2024.102443.


Analysis of Exon Skipping Applicability for Dysferlinopathies.

Leckie J, Rodriguez S, Krahn M, Yokota T Cells. 2025; 14(3).

PMID: 39936969 PMC: 11817064. DOI: 10.3390/cells14030177.


Cryo-EM structures of the membrane repair protein dysferlin.

Huang H, Grandinetti G, Heissler S, Chinthalapudi K Nat Commun. 2024; 15(1):9650.

PMID: 39511170 PMC: 11544258. DOI: 10.1038/s41467-024-53773-6.


Fish Oil Supplement Mitigates Muscle Injury In Vivo and In Vitro: A Preliminary Report.

Russ D, Sehested C, Banford K, Weisleder N Nutrients. 2024; 16(20).

PMID: 39458505 PMC: 11510179. DOI: 10.3390/nu16203511.